Teva Pharmaceutical Industries (TEVA) gained 6% after the FDA approved Weltruza, its monthly long acting injectable treatment for schizophrenia in adults.
Join our Mailing list!
Sign up to get all the latest financial news and business updates.
Please fill in the form and we will get in touch with you shortly and help answer any questions you may have about Offshore Supporting services.
